image
Tonix Pharmaceuticals Holding Corp. TNXP
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.1311
-6.36 %
$ 24.5 M
Market Cap
0.0
P/E
BALANCE SHEET
154 M ASSETS
-31.56%
Growth Rates
1Year -31.56%
3Years 16.30%
5Years 42.46%
7Years 27.95%
10Years 33.28%
48.9 M LIABILITIES
164.38%
Growth Rates
1Year 164.38%
3Years 66.85%
5Years 79.10%
7Years 56.28%
10Years 36.22%
106 M EQUITY
-49.07%
Growth Rates
1Year -49.07%
3Years 6.38%
5Years 34.85%
7Years 22.59%
10Years 32.12%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Tonix Pharmaceuticals Holding Corp.
image
Current Assets 47.8 M
Cash & Short-Term Investments 24.9 M
Receivables 4.59 M
Other Current Assets 18.2 M
Non-Current Assets 107 M
Long-Term Investments 0
PP&E 94.9 M
Other Non-Current Assets 11.8 M
Current Liabilities 18.9 M
Accounts Payable 3.78 M
Short-Term Debt 2.62 M
Other Current Liabilities 12.5 M
Non-Current Liabilities 30 M
Long-Term Debt 7.19 M
Other Non-Current Liabilities 22.9 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008
ASSETS
Cash & Cash Equivalents 24.9 120.2 178.7 77.1 11.2 25.0 25.5 18.9 19.2 38.2 8.2 1.8 41.1 K 4.62 K 12.6 K 40.5 K
Short Term Investments 0 0 0 0 0 0 0 7.2 23.8 0 0 0 0 0 425 4.88 K
Receivables 4.6 0 7.7 7.6 0 0 0 0 2.8 0 0 0 0 0 0 552
Inventory 14.1 (8.0) (7.7) (7.6) (1.0) 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 4.1 10.5 2.7 3.3 1.7 1.0 0.5 0.6 0.5 1.2 0.9 0.2 0.1 23.3 K 0 0
Total Current Assets 47.8 130.8 189.0 88.0 13.9 26.1 26.4 27.1 46.4 39.0 8.6 2.0 0.1 4.62 K 13 K 45.9 K
PP&E 94.9 94.5 51.5 9.8 0.4 43 K 91 K 0.1 0.3 0.3 45 K 46.9 K 25.6 K 0 0 0
Intangible Assets 9.7 0.1 0 0.1 0.1 0.1 0.1 0.1 0.1 0 0 0 0 0 0 0
Goodwill 1.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0.2 0.2 0.2 100 K 100 K 89 K 89 K 0.2 0 0 0 0 0 0 0
Other Long Term Assets 1.1 0.1 0.3 0.2 100 K 100 K 100 K 100 K 0.2 (13 226.0) 60 K 60.3 K 0.3 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 154.5 225.7 240.9 98.2 14.6 26.3 26.8 27.5 47.0 39.5 8.7 2.1 0.4 4.62 K 13 K 45.9 K
LIABILITIES
Accounts Payable 3.8 8.1 13.3 4.6 3.1 1.4 1.3 0.9 3.0 1.5 0.8 0.8 0.7 0.3 988 0
Short Term Debt 2.6 0.4 0.5 0.6 0.4 0 0 0 0 0 0.3 0 0.1 0 0 0
Other Current Liabilities 9.5 6.4 5.1 2.5 1.0 1.3 0.8 1.2 3.6 1.9 1.2 0.3 80.1 K 22.5 K 0 3 K
Total Current Liabilities 18.9 18.2 21.7 9.8 5.1 2.7 2.1 2.1 6.7 3.4 2.2 1.1 0.9 10.3 K 988 3 K
Long Term Debt 7.2 0.3 0.5 0.7 6 K 0 0 0 0 0 0 0 1.9 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 22.9 0 0 0 0 0 0 0 0 68 K 13 K 0 29.1 K 0 0 0
Total Liabilities 48.9 18.5 22.2 10.5 5.1 2.7 2.1 2.1 6.8 3.5 2.2 1.2 2.9 10.3 K 988 3 K
EQUITY
Common Stock 59 K 76 K 0.5 0.2 9 K 3 K 8 K 4 K 19 K 11 K 6 K 43.2 K 27.1 K 5.5 K 5.5 K 5.5 K
Retained Earnings (600.7) (470.0) (359.8) (267.5) (217.1) (188.5) (162.4) (141.2) (102.4) (54.3) (26.7) (15.8) (6.4) 70.7 K 53 K 22.1 K
Other Accumulative Comprehensive Income/Loss (0.2) (0.2) 92 K 62 K 46 K 41 K 12 K 7 K 17 K 2 K 1 K 31.6 K 17.3 K 0 0 0
Total Equity 105.5 207.2 218.7 87.6 9.4 23.7 24.6 25.4 40.3 36.1 6.5 1.0 (2.5) 5.68 K 12 K 42.9 K
Total Liabilities and Equity 154.5 225.7 240.9 98.2 14.6 26.3 26.8 27.5 47.0 39.5 8.7 2.1 0.4 4.62 K 13 K 45.9 K
SHARES OUTSTANDING
Common Shares Outstanding 0.5 0.2 56.9 K 14.8 K 0 0 0 0 0 0 0 0 6 1 1 1